Abstract: Described herein are methods and systems related to the use of the pre-existing ion injection pathway of a mass spectrometer to perform beam-type collision-activated dissociation, as well as other dissociation methods. The methods can be practiced using a wide range of mass spectrometer configurations and allows MSn experiments to be performed on very basic mass spectrometers, even those without secondary mass analyzers and/or collision cells. Following injection and selection of a particular ion type or population, that population can be fragmented via beam-type collision-activated dissociation (CAD), as well as other dissociation methods, using the pre-existing ion injection pathway or inlet of a mass spectrometer. For CAD applications, this is achieved by transmitting the ions back along the ion injection pathway with a high degree of kinetic energy. As the ions pass into the higher pressure regions located in or near the atmospheric pressure inlet, the ions are fragmented and then trapped.
Abstract: The present invention provides for methods of treating and slowing the onset of heart failure. The inventors have determined that myosin binding to unphosphorylated Myosin Binding Protein C (MyBP-C) plays a key role in the diminution of cardiac contractile force and frequency in heart failure. The present invention provides peptide inhibitors of the MyBP-C/myosin interaction, thereby increasing both cardiac contractile force and frequency in the failing heart, as well as in patients not yet exhibiting frank heart failure.
Abstract: Disclosed are metal-bound tetracarbene catalysts, such as iron based aziridination catalyst, having the formula: wherein X is a group 6, 7, 8, 9, or 10 metal and wherein Z is a hydrogen, alkyl, aryl or organic group, wherein the alkyl, aryl or organic group is optionally are independently substituted. In a specific example, a metal-bound tetracarbene catalyst has the formula: Also disclosed are methods of making (synthesizing), transmetallation reagents, these agents, metal-bound tetracarbene catalysts, and a method of catalytic alkene aziridination, using the disclosed metal-bound tetracarbene catalysts.
Type:
Grant
Filed:
June 25, 2013
Date of Patent:
June 9, 2015
Assignee:
University of Tennessee Research Foundation
Inventors:
David Matthew Jenkins, Steven Alan Cramer, Zheng Lu
Abstract: A multidimensional spectrometer encodes frequency information into laser pulses so that a frequency insensitive detector may be used to collect data for a multi-dimensional spectrograph only from intensity information and knowledge of a modulation providing the encoding. In one embodiment the frequency encoding may be done by a conventional interferometer greatly simplifying construction of the spectrometer.
Type:
Grant
Filed:
March 14, 2011
Date of Patent:
June 9, 2015
Assignee:
Wisconsin Alumni Research Foundation
Inventors:
Martin T. Zanni, Peter Hamm, Jan Helbing
Abstract: Transistor-based particle detection systems and methods may be configured to detect charged and non-charged particles. Such systems may include a supporting structure contacting a gate of a transistor and separating the gate from a dielectric of the transistor, and the transistor may have a near pull-in bias and a sub-threshold region bias to facilitate particle detection. The transistor may be configured to change current flow through the transistor in response to a change in stiffness of the gate caused by securing of a particle to the gate, and the transistor-based particle detection system may configured to detect the non-charged particle at least from the change in current flow.
Type:
Grant
Filed:
January 23, 2013
Date of Patent:
June 9, 2015
Assignee:
Purdue Research Foundation
Inventors:
Ankit Jain, Pradeep R. Nair, Muhammad Ashraful Alam
Abstract: The present method describes a new method for the measurement of dark adaptation. The dark adaptation status of subjects may then be used to identify those subjects who are at risk of developing and/or who are currently suffering from a variety of disease states having their clinical manifestations in impaired dark adaptation. The disease states include, but are not limited to, age related macular degeneration, vitamin A deficiency, Sorsby's Fundus Dystrophy, late autosomal dominant retinal degeneration, retinal impairment related to diabetes and diabetic retinopathy. An apparatus for administering the test method described is also provided.
Abstract: A single electron tunneling force spectroscopy (SETFS) system (10) can perform a series of surface potential charge measurements at an array of voltages (V) and tip-sample heights (Z). These measurements are combined with a tunneling model that includes the dependence of the tunneling probability on trap state depth and energy. Simultaneous measurement of the depth and energy of individual trap states in a sample, such as a dielectric film, with an atomic scale of spatial resolution can be achieved. When combined with two-dimensional trap state imaging, such techniques provide for three-dimensional imaging of electronic defect states with atomic scale spatial resolution.
Type:
Grant
Filed:
July 31, 2014
Date of Patent:
June 9, 2015
Assignee:
The University of Utah Research Foundation
Inventors:
Clayton Covey Williams, Jon Paul Johnson
Abstract: The present invention provides a method of inhibiting the growth of or promoting differentiation and destruction of cancer stem cells (CSCs) comprising contacting the cancer stem cells with a compound having the structure: or a pharmaceutically acceptable salt thereof.
Type:
Application
Filed:
June 28, 2013
Publication date:
June 4, 2015
Applicants:
CHEM-MASTER INTERNATIONAL, INC., The Research Foundation for the State University of New York
Inventors:
Lorne M. Golub, Francis Johnson, Galina I. Botchkina, Iwao Ojima
Abstract: The present invention features compositions and methods for the detection or measurement of oxalate in a sample. Such compositions include test devices that provide for the rapid and accurate detection of oxalate in a sample from a biological fluid. Advantageously, the compositions can be used to monitor the oxalate levels of a patient at a point of care (e.g., at the patient's home, clinic, physician's office, or other clinical setting).
Type:
Grant
Filed:
February 7, 2012
Date of Patent:
June 2, 2015
Assignee:
University of Florida Research Foundation, Inc.
Inventors:
Ammon B. Peck, Cuong Q. Nguyen, Nigel G. John Richards
Abstract: A process to produce an aqueous solution of carbohydrates that contains C6-sugar-containing oligomers, C6 sugar monomers, C5-sugar-containing oligomers, C5 sugar monomers, or any combination thereof is presented. The process includes the steps of reacting biomass or a biomass-derived reactant with a solvent system including a lactone and water, and an acid catalyst. The reaction yields a product mixture containing water-soluble C6-sugar-containing oligomers, C6-sugar monomers, C5-sugar-containing oligomers, C5-sugar monomers, or any combination thereof. A solute is added to the product mixture to cause partitioning of the product mixture into an aqueous layer containing the carbohydrates and a substantially immiscible organic layer containing the lactone.
Type:
Grant
Filed:
January 8, 2013
Date of Patent:
June 2, 2015
Assignee:
Wisconsin Alumni Research Foundation
Inventors:
James A. Dumesic, Jeremy S. Luterbacher
Abstract: The present invention provides the amino acid and polynucleotide sequences of the transcobalamin receptor, as well as modulators of the transcobalamin receptor. Accordingly, the present invention provides compositions and methods for the treatment and prevention of diseases and disorders associated with cobalamin deficiency, including compositions and methods that promote cobalamin uptake. In addition, the present invention provides compositions and methods for the detection, treatment, and prevention of diseases associated with deregulated cell growth, including, e.g., cancer and autoimmune disorders, including compositions and methods that inhibit cobalamin uptake.
Type:
Grant
Filed:
August 14, 2013
Date of Patent:
June 2, 2015
Assignee:
The Research Foundation of State University of New York
Abstract: The present invention provides an adjuvant for cancer antigen peptide vaccines and virus antigen peptides, containing a pertussis vaccine as a primary ingredient. The present invention also provides a therapeutic agent for a cancer or viral infectious disease, and a prophylactic agent for metastasis or recurrence of cancer or onset of virus-induced tumor, containing a cancer antigen peptide or virus antigen peptide and a pertussis vaccine. A pertussis vaccine that can be suitably used is a whole cell body pertussis vaccine. The agents of the present invention can be safely administered in a plurality of doses.
Type:
Grant
Filed:
February 7, 2008
Date of Patent:
June 2, 2015
Assignees:
NEC Corporation, The Research Foundation for Microbial Disease of Osaka University, National University Corporation Kochi University
Abstract: Transgenic lignocellulosic plants are provided according to embodiments of the present invention, the transgenic plants transformed with an expression cassette encoding a protein operably linked to a signal peptide which targets the protein to a cell wall of the transgenic plant, where at least 5% of the total amino acid residues of the protein are tyrosine, lysine, serine, threonine or cysteine. Methods of increasing lignin-protein bonds in a lignocellulosic plant are provided according to embodiments of the present invention which include expressing a recombinant nucleic acid in a lignocellulosic plant, the recombinant nucleic acid encoding a protein operably linked to a signal peptide which targets the protein to the cell wall of a plant, where at least 5% of the total amino acid residues of the protein are tyrosine, lysine, serine, threonine or cysteine.
Abstract: Non-natural oligomers have recently shown promise as functional analogues of lung surfactant proteins Band C (SP-B and SP-C), two helical and amphiphilic proteins that are clitical for normal respiration. The generation of non-natural mimics of SP-B and SP-C has previously been restlicted to step-by-step, sequence-specific synthesis, which results in discrete oligomers that are intended to manifest specific structural attributes. Presented herein an alternative approach to SP-R mimicry that is based on sequence-random copolymers containing cationic and lipophilic subunits. These materials, members of the nylon-3 family, arc prepared by ling-opening polymelization of 13-lactams. The best of the nylon-3 polymers display promising in vitro surfactant activities in a mixed lipid film. Pulsating bubble surfactometry data indicate that films containing the most surface-active polymers attain adsorptive and dynamic-cycling properties that surpass those of discrete peptides intended to mimic SP-B.
Type:
Grant
Filed:
March 17, 2011
Date of Patent:
June 2, 2015
Assignees:
Wisconsin Alumni Research Foundation, Northwestern University
Inventors:
Samuel H. Gellman, Shannon S. Stahl, Brendan P. Mowery, Annelise Barron, Michelle Dohm
Abstract: Identifying valid wireless access points based on clock skews. A computing device receives plurality of frames, each including a corresponding timestamp, from a wireless access point. The computing device calculates transmit and receive offsets based on transmit and receive times of the plurality of frames, and also calculates differences between the transmit and receive offsets. The computing device also calculates a clock skew of a clock at the wireless access point based on a slope of the differences. The client computing device determines whether the wireless access point is an authorized wireless access point or an unauthorized wireless access point based on comparing the calculated clock skew with one or more known baseline clock skews of one or more authorized wireless access points.
Abstract: An object-based approach is used to initialize the magnetic field inhomogeneity estimation for chemical species separation, such as water-fat separation, and other imaging applications. For example, a susceptibility distribution in the subject being imaged is estimated from images reconstructed from single-echo or multi-echo k-space data and used to initialize the magnetic field inhomogeneity estimation. This approach can be applied to any complex-based chemical shift encoded chemical species separation technique and to other imaging applications, such as susceptibility-weighted imaging and quantitative susceptibility mapping. The field map can also be used to correct for image distortions and to generate magnetic field shimming values.
Type:
Application
Filed:
November 25, 2013
Publication date:
May 28, 2015
Applicant:
Wisconsin Alumni Research Foundation
Inventors:
Samir Dev Sharma, Nathan Samuel Artz, Scott Brian Reeder
Abstract: The invention provides compounds and methods, for example, to carry out organocatalytic Michael additions of aldehydes to cyclically constrained nitroethylene compounds catalyzed by a proline derivative to provide cyclically constrained ?-substituted-?-nitro-aldehydes. The reaction can be rendered enantioselective when a chiral pyrrolidine catalyst is used, allowing for Michael adducts in nearly optically pure form (e.g., 96 to >99% e.e.). The Michael adducts can bear a single substituent or dual substituents adjacent to the carbonyl. The Michael adducts can be efficiently converted to cyclically constrained protected ?-amino acid residues, which are essential for systematic conformational studies of ?-peptide foldamers. New methods are also provided to prepare other ?-amino acids and peptides. These new building blocks can be used to prepare foldamers, such as ?/?-peptide foldamers, that adopt specific helical conformations in solution and in the solid state.
Type:
Application
Filed:
January 28, 2014
Publication date:
May 28, 2015
Applicant:
Wisconsin Alumni Research Foundation
Inventors:
Samuel Helmer Gellman, Li Guo, Michael Giuliano
Abstract: Disclosed herein are methods and materials for producing a more developmentally potent cell from a less developmentally potent cell. Specifically exemplified herein are methods that comprise introducing an expressible dedifferentiating polynucleotide sequence into a less developmentally potent cell, wherein the transfected less developmentally potent cell becomes a more developmentally potent cell capable of differentiating to a less developmentally potent cell of its lineage of origin or a different lineage.
Type:
Application
Filed:
December 8, 2014
Publication date:
May 28, 2015
Applicant:
University of Central Florida Research Foundation, Inc.
Abstract: Apparatuses and methods for detecting hidden or modified objects in a vehicle are disclosed. Embodiments include detection of vehicle irregularities, such as irregularities in the acoustical response of a vehicle tire as the tire rolls over a surface, irregularities in the orientation of the vehicle body, the response of a vehicle component (such as an axle, wheel, tire, etc.) to the vehicle moving over a surface, and the response of a vehicle component to vehicle generated vibrations. In alternate embodiments subsystems detecting different irregularities communicate with one another.
Abstract: Technology for deep brain stimulating including devices, systems, computer circuitry, and associated methods is provided. A deep brain stimulating device (100) can include a semiconductor substrate, an array of electrodes (140) coupled to the semiconductor substrate, and circuitry operable to control the array of electrodes (140). Each electrode (142) can be operable to function as an anode, a cathode, a common, or a float independent of other electrodes in the array to create highly configurable electric fields (122, 124).
Type:
Application
Filed:
May 16, 2013
Publication date:
May 28, 2015
Applicant:
University of Utah Research Foundation
Inventors:
Alan Dale Dorvall, II, Andrew Colin Willsie